Device for Emergency Room to Triage Patients

This product addresses UGIB both as an inpatient and in a triage setting. Today in the United States 1.1M patients attend ER for suspected bleeding but only two thirds of them are diagnosed with actual bleeding. This device offers a solution for the emergency room to triage patients more efficiently. Additionally, of the patients hospitalised with UGIB, a high percentage are high-risk and require monitoring after treatment. This device offers a unique solution for real-time monitoring of these patients for up to 3 days. The total market potential for this product in Europe and in the United States is $1.6B.